| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |